Dublin-based drugs maker Shire said Monday it had entered "detailed discussions" with AbbVie about a $54 billion takeover proposal. It is AbbVie's fifth takeover proposal for Shire. If the deal is successful, the combined entity would become the ninth-largest drugs company in the world. Meanwhile, other U.S. companies looking to reduce their tax bills by switching their domicile have recently failed to acquire London-listed healthcare targets. Pfizer for instance, pulled a roughly $120 billion bid for AstraZeneca in late May after the latter rejected a string of proposals. The Deal's Sarah Pringle spoke with The Deal's European Editor Laura Board about the deal.

More from Video

TheStreet Rewind: How to Make 'New Fashioned Wall Streeter'; Twist on a Classic

TheStreet Rewind: How to Make 'New Fashioned Wall Streeter'; Twist on a Classic

Thankfully Our Favorite #FearlessGirl is Not Going Anywhere

Thankfully Our Favorite #FearlessGirl is Not Going Anywhere

Jim Cramer: Will Apple or Amazon Become the World's First Trillion Dollar Stock?

Jim Cramer: Will Apple or Amazon Become the World's First Trillion Dollar Stock?

It's Dumb to Think Legalizing Weed Is Still a Political Issue

It's Dumb to Think Legalizing Weed Is Still a Political Issue

Video: How to Select Mutual Funds in Your 401(k)

Video: How to Select Mutual Funds in Your 401(k)